草津眼科クリニック文字.jpg

緑内障と白内障の診断・治療・手術 / 眼科一般診療

広島市西区草津東2丁目16-8
お問い合わせ:082-208-1700

院長業績

<著書>

1. 「層間分離と血管断面の止血」, 谷原秀信 編集, 眼科インストラクションコース14 トラベクレクトミー完全マスター; 62-65頁, メジカルビュー, 2008.

2. 「第5章 Krupinアイバルブ」, 谷原秀信 翻訳編集, 動画で分かる緑内障手術; 中山書店, 73-83頁, 2010. ;The Krupin eye valve with disk; Farrokh-Siar L, Krupin T In: Chen T (ed.) Surgical Techniques in Ophthalmology Series: Glaucoma Surgery の和訳

3. "Chapter 26 Plateau iris" In: Glaucoma - Basic and Clinical Concepts, Shimon Rumelt (ed.), InTech, 523-534, 2011.

4. 「プラトー虹彩緑内障」, 木内良明 編集, 緑内障診療クローズアップ; 216-225頁, メジカルビュー, 2014.

5. 「急性原発閉塞隅角症」, 木内良明 編集, 緑内障診療クローズアップ; 216-225頁, メジカルビュー, 2014.

6. 「周術期の標準的な管理」, 杉山和久・谷原秀信 編集, 緑内障治療のアップデート; 209-217頁, 医学書院, 2015.

<総説>

1. 【覚えておかなきゃ危ない! 患者さんに禁忌の薬】 他の疾患に禁忌の眼科の薬編
全身疾患に気を付けなくてはいけない緑内障点眼薬は?
眼科ケア, 14: 1210-1212, 2012.

2. 【眼科薬物療法】 配合剤とアドヒアランス
眼科, 54: 1332-1333, 2012.

3. 【わかりやすい緑内障薬物のお話】 β遮断薬
あたらしい眼科, 29: 451-455, 2012.

4. 【他科に聞く】 緑内障
広島県内科会誌, 14: 52-56, 2014.

5. 【糖尿病網膜症の診察】血管新生緑内障
Oculista, No.8: 63-69, 2013.

6. 高齢者の眼疾患の特徴と治療
臨床老年看護, 24(5・6): 29-39, 2017.

<英文原著>

1: Sugimoto Y, Mochizuki H, Ohkubo S, Higashide T, Sugiyama K, Kiuchi Y;
Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment Study.
Ophthalmology. 2015 Nov;122(11):2223-33.

2: Yamamoto T, Sawada A, Mayama C, Araie M, Ohkubo S, Sugiyama K, Kuwayama Y;
Collaborative Bleb-Related Infection Incidence and Treatment Study Group.
The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C:
collaborative bleb-related infection incidence and treatment study 2.
Ophthalmology. 2014 May;121(5):1001-6.  (Study Groupの一員)

3: Rimayanti U, Kiuchi Y, Uemura S, Takenaka J, Mochizuki H, Kaneko M.
Ocular Surface Displacement with and without Contact Lenses during Non-Contact Tonometry.
PLoS One. 2014 Apr 29;9(4):e96066.

4: Rimayanti U, Kiuchi Y, Yamane K, Latief MA, Mochizuki H, Hirata J, Akita T, Tanaka J.
Inner retinal layer comparisons of eyes with exudative age-relatedmacular degeneration and eyes with age-related macular degeneration and glaucoma.
Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):563-70.

5: Nakakura S, Kiuchi Y, Kaneko M, Mochizuki H, Takenaka J, Yamada K, Kimura Y, Tabuchi H.
Evaluation of corneal displacement using high-speed photography at the early and late phases of noncontact tonometry.
Invest Ophthalmol Vis Sci. 2013 Apr 3;54(4):2474-82.

6: Sugimoto Y, Mochizuki H, Miyagi H, Kawamata S, Kiuchi Y.
Histological findings of uveal capillaries in rabbit eyes after multiple intravitreal injections of bevacizumab.
Curr Eye Res. 2013 Apr;38(4):487-96.

7: Mochizuki H, Takenaka J, Sugimoto Y, Kiuchi Y.
Plateau iris and ultrasound biomicroscopy.
J Glaucoma. 2013 Mar;22(3):267-8.

8: Kiuchi Y, Kaneko M, Mochizuki H, Takenaka J, Yamada K, Tanaka J.
Corneal displacement during tonometry with a noncontact tonometer.
Jpn J Ophthalmol. 2012 May;56(3):273-9.

9: Mochizuki H, Murphy CJ, Brandt JD, Kiuchi Y, Russell P.
Altered stability of mRNAs associated with glaucoma progression in human trabecular meshwork cells following oxidative stress.
Invest Ophthalmol Vis Sci. 2012 Apr 2;53(4):1734-41.

10: Takenaka J, Mochizuki H, Kunihara E, Tanaka J, Kiuchi Y.
Intraocular pressure measurement using rebound tonometer for deviated angles and positions in human eyes.
Curr Eye Res. 2012 Feb;37(2):109-14.

11: Yamada T, Mochizuki H, Ue T, Kiuchi Y, Takahashi Y, Oinaka M.
Comparative study of different β-radiation doses for preventing pterygium recurrence.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1394-8.

12: Mochizuki H, Lesley AG, Brandt JD
Shrinkage of the scleral canal during cupping reversal in children.
Ophthalmology. 2011 Oct;118(10):2008-13.

13: Mochizuki H, Takenaka J, Sugimoto Y, Takamatsu M, Kiuchi Y.
Comparison of the prevalence of plateau iris configurations between angle-closure glaucoma and open-angle glaucoma using ultrasound biomicroscopy.
J Glaucoma. 2011 Jun-Jul;20(5):315-8.

14: Takenaka J, Mochizuki H, Kunihara E, Tanaka J, Kiuchi Y.
Evaluation of rebound tonometer for measuring intraocular pressure at deviated angle and position.
Curr Eye Res. 2011 May;36(5):422-8.

15: Sugimoto Y, Mochizuki H, Okumichi H, Takumida M, Takamatsu M, Kawamata S, Kiuchi Y.
Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1601-9.

16: Mochizuki H, Itakura H, Yokoyama T, Takamatsu M, Kiuchi Y.
Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects.
Jpn J Ophthalmol. 2010 Jul;54(4):286-90.

17: Kiuchi Y, Tsujino C, Nakamura T, Otori Y, Mochizuki H.
Phacoemulsification and trabeculotomy combined with goniosynechialysis for uncontrollable chronic angle-closure glaucoma.
Ophthalmic Surg Lasers Imaging. 2010 May-Jun;41(3):348-54.

18: Toda R, Mochizuki H, Sone T, Kiuchi Y.
Changes in optic disc shape and size in two patients with suspected glaucoma during a two- and three-year follow-up period.
Jpn J Ophthalmol. 2010 Jan;54(1):94-6.

19: Nobukuni M, Mochizuki H, Okada S, Kameyama N, Tanaka A, Yamamoto H, Amano T, Seki T, Sakai N.
The C-terminal region of serotonin transporter is important for its trafficking and glycosylation.
J Pharmacol Sci. 2009 Dec;111(4):392-404.

20: Mochizuki H, Itakura H, Takamatsu M, Kiuchi Y.
Efficacy of latanoprost when stored at room temperature.
Hiroshima J Med Sci. 2008 Jun;57(2):69-72.

21: Mochizuki H, Seki T, Adachi N, Saito N, Mishima HK, Sakai N.
R659S mutation of gammaPKC is susceptible to cell death: implication of this mutation/polymorphism in the pathogenesis of retinitis pigmentosa.
Neurochem Int. 2006 Dec;49(7):669-75.

22: Seki T, Adachi N, Ono Y, Mochizuki H, Hiramoto K, Amano T, Matsubayashi H, Matsumoto M, Kawakami H, Saito N, Sakai N.
Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death.
J Biol Chem. 2005 Aug 12;280(32):29096-106.

23: Mochizuki H, Amano T, Seki T, Matsubayashi H, Mitsuhata C, Morita K, Kitayama S, Dohi T, Mishima HK, Sakai N.
Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT).
Neurochem Int. 2005 Jan;46(2):93-105.

24: Noma H, Sakamoto I, Mochizuki H, Tsukamoto H, Minamoto A, Funatsu H, Yamashita H, Nakamura S, Kiriyama K, Kurihara H, Mishima HK.
Relationship between periodontal disease and diabetic retinopathy.
Diabetes Care. 2004 Feb;27(2):615.

25: Funatsu H, Yamashita H, Noma H, Mochizuki H, Mimura T, Ikeda T, Hori S.
Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1042-7.

26: Okada K, Tsukamoto H, Masumoto M, Jian K, Okada M, Mochizuki H, Mishima HK.
Autologous blood injection for marked overfiltration early after trabeculectomy with mitomycin C.
Acta Ophthalmol Scand. 2001 Jun;79(3):305-8.

27: Tsukamoto H, Yokoyama T, Okada K, Okada M, Mochizuki H, Mishima HK.
Substituting latanoprost (Xalatan) for isopropyl unoprostone (Rescula) in monotherapy and combination therapy.
Acta Ophthalmol Scand. 2000 Oct;78(5):604-5.

<和文原著>

19報 (省略)

<国際学会発表>

1. Substituting latanoprost (Xalatan) for isopropyl unoprostone (Rescula) in monotherapy and combination therapy.
第6回ヨーロッパ緑内障学会, イギリス, ロンドン, 2000年.

2. The effect and limitation of trabeculotomy, outflow re-construction surgery.
アジア・オセアニア緑内障学会, タイ, バンコク, 2007年.

3. Shrinkage of the scleral canal during cupping reversal in children.
第20回アメリカ緑内障学会, フロリダ, ネイプルス, 2010年.

4. Altered stability of mRNAs associated with glaucoma progression in human trabecular meshwork cells following oxidative stress.
アメリカ眼科視覚研究学会, フロリダ, フォートローダーデール, 2011年

5. Altered stability of mRNAs associated with glaucoma progression in human trabecular meshwork cells following oxidative stress.
第21回アメリカ緑内障学会, カリフォルニア, デイナポイント, 2011年.

6. Effect of Rho kinase inhibitor on stability of mRNAs associated with glaucoma progression in human trabecular meshwork cells following oxidative stress.
アメリカ眼科視覚研究学会, ワシントン, シアトル, 2013年.

7. Intraocular pressure-lowering efficacy and safety of 0.4% ripasudil.
アメリカ眼科視覚研究学会, ワシントン, シアトル, 2016年.

<国内学会発表>

多数 (省略)